Long-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experience.

Neurol Sci 2009 Jun 22;30(3):193-9. Epub 2009 Apr 22.

Centro Studi Sclerosi Multipla, Ospedale di Gallarate, Via Pastori 4, 20013, Gallarate, Italy.

The main objective of this study is to evaluate the effect of immunomodulatory agents (IMAs) (Interferon-Beta, Glatiramer Acetate) in a large cohort of multiple sclerosis (MS) patients with disease onset in childhood or adolescence, treated before 16 years of age, after a long-term follow-up. A total of 130 patients were identified, 77 were treated with Avonex, 39 with Rebif/Betaferon, 14 with Copaxone. After a mean (SD) treatment duration of 53.6 +/- 27.0, 59.9 +/- 39.5 and 74.6 +/- 35.5 months, respectively, the relapse rate decreased significantly. The final EDSS score was unchanged with respect to the initial score. Similar results were also observed in subjects who continued a long-term follow-up after they were included in an observational study in 2004, and in subjects who were treated before 12 years of age. The frequency of clinical and laboratory adverse events was similar to that observed in adult patients. To conclude, IMAs were effective and well tolerated in paediatric patients with MS.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10072-009-0083-1DOI Listing
June 2009
4 Reads

Publication Analysis

Top Keywords

multiple sclerosis
8
long-term follow-up
8
years age
8
treated years
8
age frequency
4
rebif/betaferon copaxone
4
copaxone treatment
4
treatment duration
4
+/- 270
4
270 599
4
subjects treated
4
avonex rebif/betaferon
4
536 +/-
4
duration 536
4
identified treated
4
total 130
4
follow-up total
4
laboratory adverse
4
adolescence treated
4
130 patients
4

References

(Supplied by CrossRef)

E Waubant et al.
Neuropediatrics 2001

Y Mikaeloff et al.
J Pediatr 2001

D Pohl et al.
Neurology 2005

B Banwell et al.
Neurology 2006

SN Tenembaum et al.
Neurology 2006

H Pakdaman et al.
Neuropediatrics 2006

A Ghezzi et al.
Neurol Sci 2005

A Ghezzi et al.
Neurol Sci 2007

WI McDonald et al.
Ann Neurol 2001

Similar Publications